Kelsey Parfitt
Physician Assistant · du Bois, PANPI 1255784781
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $8,997 of the $12,646 with a category attached, or 71.1%. 48 manufacturers reported payments, led by Gilead at 34.6% of the total. 2025 is the largest year on record at $4,963, 3.3 times the $1,512 reported in 2021. Among physician assistant clinicians in PA with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 531 payments — averaging $23.81 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Gilead$4K
- AbbVie$2K
- Viiv Healthcare Company$1K
- Organogenesis Inc.$755
- Insmed, Inc.$710
- Novo Nordisk$555
- plus $3K from 42 others
What the payments were for
- Consulting fees$2,39019%
- Travel & lodging$9778%
- Food & beverage$8,99771%
- Education$2812%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$12,646 in reported general payments places this provider in the 95th percentile of 6,643 physician assistant providers in Pennsylvania.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| DovatoDolutegravir Sodium/Lamivudine | 11 | $32,915 |
| OzempicSemaglutide | 21 | $20,244 |
| Trelegy ElliptaFluticasone/Umeclidin/Vilanter | 16 | $10,144 |
| JardianceEmpagliflozin | 12 | $8,419 |
| EliquisApixaban | 15 | $8,062 |
| Methenamine Hippurate | 16 | $803 |
| Cefadroxil | 22 | $663 |
| Cefdinir | 12 | $355 |
| ValacyclovirValacyclovir Hcl | 15 | $289 |
| Levothyroxine Sodium | 14 | $265 |
| Doxycycline Hyclate | 28 | $200 |
| Rosuvastatin Calcium | 16 | $195 |
| Atorvastatin Calcium | 19 | $168 |
| Lisinopril | 20 | $87 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Viiv Healthcare CompanyDovato | $1,130 | $32,91511 claims |
| Novo NordiskOzempic | $555 | $20,24421 claims |
| GSKTrelegy Ellipta | $48 | $10,14416 claims |
| PfizerEliquis | $73 | $8,06215 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 6,643 physician assistant providers in Pennsylvania.
Other physician assistant in du Bois
- Amy Clevengerdu Bois$21K
- Cassandra Foradoridu Bois$18K
- Erin CrownState College$1.2M
- Tricia BootsCranberry Twp$313K
- Melissa FerrariPhiladelphia$223K
- Jason OberdickWexford$206K
- Justine RobertsMurrysville$173K
- Allison BoydErie$163K
- Joshua TrbovichWashington$144K
- Daniel TelegaErie$124K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.